Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapy

BACKGROUND: Frailty, sarcopenia and malnutrition are powerful predictors of clinical outcomes that are not routinely measured in patients with non-small cell lung cancer (NSCLC). The primary aim of this study was to investigate the association of sarcopenia, determined by the psoas muscle index (PMI...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolte, Fabian J., McTavish, Sloane, Wakefield, Nathan, Shantzer, Lindsey, Hubbard, Caroline, Krishnaraj, Arun, Novicoff, Wendy, Gentzler, Ryan D., Hall, Richard D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539742/
https://www.ncbi.nlm.nih.gov/pubmed/36212442
http://dx.doi.org/10.3389/fonc.2022.986236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539742/
https://www.ncbi.nlm.nih.gov/pubmed/36212442
http://dx.doi.org/10.3389/fonc.2022.986236

Ejemplares similares